XBIOTECH INC. Deferred Tax Liabilities, Property, Plant and Equipment
XBIOTECH INC. (XBIT) had Deferred Tax Liabilities, Property, Plant and Equipment of $112.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-13.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Net › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment · last filed 2026-03-13
- 2025-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $112.00K.
- 2024-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $323.00K.
- 2023-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $535.00K.
- 2022-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $710.00K.
| Period end | Deferred Tax Liabilities, Property, Plant and Equipment |
|---|---|
| 2025-12-31 | $112.00K 10-K · filed 2026-03-13 |
| 2024-12-31 | $323.00K 10-K · filed 2026-03-13 |
| 2023-12-31 | $535.00K 10-K · filed 2025-03-18 |
| 2022-12-31 | $710.00K 10-K · filed 2024-03-15 |
| 2021-12-31 | $824.00K 10-K · filed 2023-03-15 |
| 2020-12-31 | $592.00K 10-K · filed 2022-03-15 |
| 2019-12-31 | $348.00K 10-K · filed 2021-03-16 |
| 2018-12-31 | $166.00K 10-K · filed 2021-03-16 |
| 2017-12-31 | $282.00K 10-K · filed 2020-03-16 |
| 2016-12-31 | $31.00K 10-K/A · filed 2019-03-15 |
| 2015-12-31 | $13.00K 10-K · filed 2018-03-16 |
| 2014-12-31 | $40.00K 10-K · filed 2017-03-16 |
| 2013-12-31 | $13.00K 10-K · filed 2016-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |